How to prepare for Affiliate-Based Outsourcing for Regulatory Affairs?

Webinar: How to prepare for Affiliate-Based Outsourcing for Regulatory Affairs?

Affiliate-Based Outsourcing (ABO) Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources, which are often insufficient for the effective organization and execution of regulatory activities. The essential element for the successful implementation of the ABO model is the company’s readiness for this change. The purpose of this webinar is to share the key steps and practical tips on the preparation for Affiliate-Based Outsourcing for Regulatory Affairs.

 

Registering your MD in the EAEU?

Make use of our experience to facilitate the approval process. Explore your options in an informal chat.
This webinar focuses on learning:

  1. Milestones in the journey towards the Affiliate-Based Outsourcing
  2. Triggers and Reasons for the Regulatory Affairs ABO
  3. Preparation for the ABO
  4. Key elements you should consider while getting ready for the Regulatory Affairs ABO

Duration: 50 minutes

Speaker: Head of Regulatory Affairs, Olga Bernardova.

Olga Bernardova

Olga Bernardova

Head of Regulatory Affairs

Other content that might interest you:

Saudi FDA’s New Pricing Guidelines and Impact on the Region

Saudi FDA’s New Pricing Guidelines and Impact on the Region

In a highly evolving regional pricing environment, Saudi Arabia (KSA) is no exception. The Saudi Food and Drug Authority (SFDA) has been periodically reviewing its pricing mechanisms and criteria so that the country becomes a regional reference for the prices of pharmaceutical products. What followed is a change in the pricing strategy by SFDA and a shift from price takers to price makers.

read more
Expert Guidance on PSURs: Ensuring Drug Safety

Expert Guidance on PSURs: Ensuring Drug Safety

The pharmaceutical industry constantly evolves, with new drugs being developed and approved daily. One critical aspect of ensuring the safety and efficacy of these medications is the periodic assessment of their risk-benefit profile. Enter Periodic Safety Update...

Literature Monitoring in Pharmacovigilance

Literature Monitoring in Pharmacovigilance

Incorporating data from medical and scientific literature is a paramount aspect of patient safety. This wealth of knowledge often constitutes a substantial part of the safety profile of medicinal products. From providing insights on potential side effects to shedding...

Big Enough To Cover All Your Needs.
Small Enough To Care.

Discover how Biomapas provides all the support to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Reliable support for every phase of your clinical trial, from recruitment to results.

Pharmacovigilance

Flexible safety monitoring to keep your products compliant and trusted.

Regulatory Affairs

Confidently navigate regulatory challenges with expert support.

Medical Information

Clear, accurate medical information 24/7, tailored for global audiences.

Quality Assurance

Export auditors help identify gaps and close them with actionable solutions.